Humans Vary, So Cardiac Models Should Account for That Too!
The utilization of mathematical modeling and simulation in drug development encompasses multiple mathematical techniques and the location of a drug candidate in the development pipeline. Historically speaking they have been used to analyze experimental data (i.e., Hill equation) and clarify the invo...
Main Authors: | Barbara Wiśniowska, Zofia Tylutki, Sebastian Polak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphys.2017.00700/full |
Similar Items
-
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating
by: Barbara Wiśniowska, et al.
Published: (2022-03-01) -
Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation
by: Marjory Moreau, et al.
Published: (2022-04-01) -
An Open-Access Dataset of Thorough QT Studies Results
by: Barbara Wiśniowska, et al.
Published: (2020-01-01) -
Improving the Working Models for Drug–Drug Interactions: Impact on Preclinical and Clinical Drug Development
by: James Nguyen, et al.
Published: (2025-01-01) -
Dynamic Mass Balance Modeling for Chemical Distribution Over Time in In Vitro Systems With Repeated Dosing
by: Sherri Bloch, et al.
Published: (2022-08-01)